Spots Global Cancer Trial Database for randomisation
Every month we try and update this database with for randomisation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | NCT00813072 | Stomach Neoplas... Esophageal Neop... | PEP02 irinotecan docetaxel | 18 Years - | PharmaEngine | |
Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom | NCT03413579 | Cervical Cancer | Nimotuzumab ( h... Placebo | 18 Years - 75 Years | El Kendi Pharmaceuticals Manufacturing Company | |
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer | NCT00349492 | Small Cell Lung... | IP | 18 Years - | Clinical Research Center for Solid Tumor, Korea | |
Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck | NCT01427478 | Head and Neck S... | AFATINIB Placebo of AFAT... | 18 Years - | Centre Leon Berard |